No signs of meaningfully different symptoms or vaccine response, experts say
Don't assume old strategies and new technologies will improve patient safety
Health news and commentary gathered by ̳ staff
Secondary analysis of trial data consistent with observational studies
Its disparate impact offers lessons in resource sharing and medical ethics
The amount of vaccine to order is "a guess," says one physician
Also in TTHealthWatch: beta-blockers after MI
Paul Offit, MD, talks about the flu, RSV, and COVID vaccines for the 2024-2025 season
Governments are slashing budgets that feed local health departments
Unlike the mRNA vaccines, protein-based vaccine targets JN.1 strain
Immediate clinical application is unclear, but prototype shows potential
Also in TTHealthWatch: myocarditis after COVID vaccination
Non-cardiovascular benefits observed in SELECT trial
Multiple cases reported on social media; few precautions in evidence at the convention